DFTX — Definium Therapeutics, Inc. stock price, charts and financials

QT91Definium Therapeutics, Inc.

Definium Therapeutics, Inc. (NASDAQ: DFTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
38.81
+0.13+0.34%
OverviewShort InterestFilings
DFTXQT91Definium Therapeutics, Inc.·NASDAQ
38.81+0.34%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20268-KCurrent report
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 04, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20268-KCurrent report
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 24, 2026424B5Prospectus
Jun 24, 20268-KCurrent report
#1 / 25 of 459
Page
▼
/ 19